Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""tuberculosis"" wg kryterium: Temat


Tytuł:
Novel rrs mutations in second-line injectable drug-resistant clinical isolates of Mycobacterium tuberculosis from the Punjab province of Pakistan.
Autorzy:
Sarwer MI; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore. 1KM Defense Road, Lahore, 58810, Pakistan. Electronic address: .
Khan MT; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore. 1KM Defense Road, Lahore, 58810, Pakistan. Electronic address: .
Khurshid S; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore. 1KM Defense Road, Lahore, 58810, Pakistan. Electronic address: sanakhurshid_.
Pokaż więcej
Źródło:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2022 Aug; Vol. 28 (8), pp. 1119-1124. Date of Electronic Publication: 2022 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Multiple, Bacterial*/genetics
Mycobacterium tuberculosis*/genetics
Mycobacterium tuberculosis*/isolation & purification
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/genetics
Antitubercular Agents/adverse effects ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Genes, Bacterial/genetics ; Humans ; Microbial Sensitivity Tests ; Mutation ; Pakistan ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Tuberculosis, Lymph Node
Czasopismo naukowe
Tytuł:
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020.
Autorzy:
Jeyashree K; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Thangaraj J; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Rade K; World Health Organization, Country Office for India, New Delhi, India.
Modi B; GMERS Medical College & Civil Hospital, Gandhinagar, Gujarat, India.
Selvaraju S; ICMR - National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Velusamy S; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Akhil S; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Vijayageetha M; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Sudha Rani D; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Sabarinathan R; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Manikandanesan S; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Elumalai R; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Natarajan M; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Joseph B; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Mahapatra A; ICMR-Regional Medical Research Centre, Bhubaneswar, Orissa, India.
Shamim A; WHO-NTEP Technical Assistance Project, New Delhi, India.
Shah A; USAID India Mission, New Delhi, Delhi, India.
Bhardwaj A; MM Medical College & Hospital, Kumarhatti, Solan, Himachal Pradesh, India.
Purty A; Pondicherry Institute of Medical Sciences, Puducherry, India.
Vadera B; Wadhwani Institute of Artificial Intelligence, Mumbai, India.
Sridhar A; WHO-NTEP Technical Assistance Project, New Delhi, India.
Chowdhury A; WHO-NTEP Technical Assistance Project, New Delhi, India.
Shafie A; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Choudhury A; World Health Organization, Country Office for India, New Delhi, India.
Dhrubjyoti D; WHO-NTEP Technical Assistance Project, New Delhi, India.
Solanki H; WHO-NTEP Technical Assistance Project, New Delhi, India.
Sirmanwar K; PATH India, New Delhi, India.
Khaparde K; WHO-NTEP Technical Assistance Project, New Delhi, India.
Parmar M; World Health Organization, Country Office for India, New Delhi, India.
Dahiya N; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Debdutta P; WHO-NTEP Technical Assistance Project, New Delhi, India.
Ahmed Q; CDC, New Delhi, Delhi, India.
Ramachandran R; World Health Organization, Country Office for India, New Delhi, India.
Prasad R; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Shinde R; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Baruah R; Gauhati Medical College, Guwahati, Assam, India.
Chauhan S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Bharaswadkar S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Achanta S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Sharath BN; ESIC Medical College and PGIMSR, Bengaluru-560010, Karnataka, India.
Balakrishnan S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Chandra S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Khumukcham S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Mandal S; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Chalil S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Shah V; WHO-NTEP Technical Assistance Project, New Delhi, India.
Roddawar V; PATH India, New Delhi, India.
Rao R; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Sachdeva K; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Murhekar M; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India .
Pokaż więcej
Corporate Authors:
Subnational TB claims verification group
Źródło:
BMJ open [BMJ Open] 2022 Jul 28; Vol. 12 (7), pp. e060197. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epidemiological Monitoring*
Tuberculosis*/diagnosis
Tuberculosis*/epidemiology
Tuberculosis*/prevention & control
Disease Eradication ; Humans ; Incidence ; India/epidemiology ; Mycobacterium tuberculosis/isolation & purification
Czasopismo naukowe
Tytuł:
Hit Compounds and Associated Targets in Intracellular Mycobacterium tuberculosis .
Autorzy:
Tsui CKM; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore 308442, Singapore.
Sorrentino F; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Narula G; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Mendoza-Losana A; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Department of Bioengineering and Aerospace Engineering, Carlos III University of Madrid, 28040 Madrid, Spain.
Del Rio RG; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Herrán EP; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Lopez A; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Bojang A; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Zheng X; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Remuiñán-Blanco MJ; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Av-Gay Y; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jul 12; Vol. 27 (14). Date of Electronic Publication: 2022 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/pharmacology
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/genetics
Bacterial Proteins/genetics ; Humans ; INDEL Mutation ; Macrophages/microbiology ; Microbial Sensitivity Tests ; Mutation ; Tuberculosis/microbiology
Czasopismo naukowe
Tytuł:
End-point definition and trial design to advance tuberculosis vaccine development.
Autorzy:
Garcia-Basteiro AL; Centro de Investigação em Sade de Manhiça (CISM), Maputo, Mozambique .; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain.
White RG; London School of Hygiene and Tropical Medicine, London, UK.
Tait D; International AIDS Vaccine Initiative (IAVI) NPC, Cape Town, South Africa.
Schmidt AC; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.
Rangaka MX; Institute for Global Health and MRC Clinical Trials Unit at University College London, London, UK.; CIDRI-AFRICA, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Quaife M; London School of Hygiene and Tropical Medicine, London, UK.
Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
Mogg R; Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand.
Harris RC; London School of Hygiene and Tropical Medicine, London, UK.; Sanofi Pasteur, Singapore.
Hanekom WA; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Division of Infection and Immunity, University College London, London, UK.
Frick M; Treatment Action Group, New York, NY, USA.
Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Evans T; Vaccitech, Oxford, UK.
Dagnew AF; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.
Churchyard G; The Aurum Institute, Parktown, South Africa.; Vanderbilt University, Nashville, TN, USA.; University of the Witwatersrand, Johannesburg, South Africa.
Cobelens F; Dept of Global Health and Amsterdam Institute for Global health and development, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Behr MA; Dept of Medicine, McGill University; McGill International TB Centre, Montreal, QC, Canada.
Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło:
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2022 Jun 07; Vol. 31 (164). Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials as Topic*/methods
Tuberculosis Vaccines*
Vaccine Development*
Adolescent ; Adult ; COVID-19/prevention & control ; Humans ; Mycobacterium tuberculosis ; Research Design ; Tuberculosis/prevention & control
Czasopismo naukowe
Tytuł:
Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis.
Autorzy:
Bai W; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Liu L; Department of Clinical Laboratory Medicine, Wenzhou Longwan First People's Hospital, Wenzhou, China.
Wu L; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Chen S; Department of Blood Transfusion, People's Hospital of Pingyang County, Wenzhou, China.
Wu S; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Wang Z; Department of Obstetrics and Gynecology, Wenzhou Central Hospital, Wenzhou, China.
Xu K; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Chi Q; Department of Respiratory and Critical Care Medicine, Key Laboratory of precision medicine of Wenzhou, Wenzhou Central Hospital, Wenzhou, China.
Pan Y; Department of Clinical Laboratory Medicine, Key Laboratory of precision medicine of Wenzhou, Wenzhou Central Hospital, Wenzhou, China.
Xu X; Department of Clinical Laboratory Medicine, Key Laboratory of precision medicine of Wenzhou, Wenzhou Central Hospital, Wenzhou, China.
Pokaż więcej
Źródło:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Jan; Vol. 36 (1), pp. e24154. Date of Electronic Publication: 2021 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/genetics
Drug Resistance, Multiple, Bacterial/*genetics
Molecular Typing/*methods
Tuberculosis, Pulmonary/*diagnosis
Adult ; Antibiotics, Antitubercular/pharmacology ; Bronchoalveolar Lavage Fluid/microbiology ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Rifampin/pharmacology ; Tuberculosis, Multidrug-Resistant/diagnosis ; Tuberculosis, Multidrug-Resistant/microbiology ; Tuberculosis, Pulmonary/microbiology
Czasopismo naukowe
Tytuł:
A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis.
Autorzy:
Berton S; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Chen L; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Liang YC; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Xu Z; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Afriyie-Asante A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Rajabalee N; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Yang W; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China. Electronic address: .
Sun J; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada; Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, ON K1H 8M5, Canada. Electronic address: .
Pokaż więcej
Źródło:
Cell chemical biology [Cell Chem Biol] 2022 Jul 21; Vol. 29 (7), pp. 1126-1139.e12. Date of Electronic Publication: 2022 Mar 22.
Typ publikacji:
Journal Article
MeSH Terms:
Autophagy*
Protein Phosphatase 2C*/antagonists & inhibitors
Tuberculosis*/drug therapy
Animals ; Macrophages/metabolism ; Macrophages/microbiology ; Mice ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Expression of mycobacterium tuberculosis induced SOCS3 and STAT3 and the implications on innate immunity in TB patients vs healthy contacts in high TB/HIV endemic setting: A cross-sectional analytical study.
Autorzy:
Lungu P; Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia.
Mushota K; USAID Sustaining Technical and Analytic Resources (STAR) Project, Lusaka, Zambia.
Njelesani E; Faculty of Medicine, Lusaka Apex Medical University, Lusaka, Zambia.
Sukwa T; Faculty of Medicine, Lusaka Apex Medical University, Lusaka, Zambia.
Lakhi S; Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia.
Mwaba P; Faculty of Medicine, Lusaka Apex Medical University, Lusaka, Zambia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 15; Vol. 17 (7), pp. e0263624. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
Immunity, Innate*/genetics
STAT3 Transcription Factor*/genetics
STAT3 Transcription Factor*/metabolism
Suppressor of Cytokine Signaling 3 Protein*/genetics
Suppressor of Cytokine Signaling 3 Protein*/metabolism
Tuberculosis*/genetics
Tuberculosis*/immunology
Cross-Sectional Studies ; Humans ; Interleukin-6/metabolism ; Mycobacterium tuberculosis/immunology ; Signal Transduction ; Suppressor of Cytokine Signaling Proteins/genetics ; Suppressor of Cytokine Signaling Proteins/metabolism ; Zambia/epidemiology
Czasopismo naukowe
Tytuł:
MicroRNA-20b carried by mesenchymal stem cell-derived extracellular vesicles protects alveolar epithelial type II cells from Mycobacterium tuberculosis infection in vitro.
Autorzy:
Yan K; Department of Respiratory Nursing, Qingdao Central Hospital, Qingdao 266034, Shandong, PR China.
Xu G; Department of Respiratory Nursing, Qingdao Central Hospital, Qingdao 266034, Shandong, PR China.
Li Z; Department of Respiratory Medicine, Linyi High-tech Zone People's Hospital, Linyi 276200, Shandong, PR China. Electronic address: Mr_.
Pokaż więcej
Źródło:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2022 Jul; Vol. 101, pp. 105292. Date of Electronic Publication: 2022 Apr 30.
Typ publikacji:
Journal Article
MeSH Terms:
Extracellular Vesicles*/genetics
Mesenchymal Stem Cells*/microbiology
MicroRNAs*/genetics
Tuberculosis*/prevention & control
A549 Cells ; Humans ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
Autorzy:
Dadlani VG; Department of Pharmaceutical Chemistry, Dr. L. H. Hiranandani College of Pharmacy, Ulhasnagar, India.
Chhabhaiya H; Department of Pharmaceutical Chemistry, Dr. L. H. Hiranandani College of Pharmacy, Ulhasnagar, India.
Somani RR; Department of Pharmaceutical Chemistry, D Y Patil University School of Pharmacy, Navi Mumbai, India.
Tripathi PK; Institute of Pharmaceutical Sciences, University of Lucknow, Lucknow, India.
Pokaż więcej
Źródło:
Chemical biology & drug design [Chem Biol Drug Des] 2022 Aug; Vol. 100 (2), pp. 230-244. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/chemistry
Antitubercular Agents*/pharmacology
Isatin*/chemistry
Isatin*/pharmacology
Mycobacterium tuberculosis*/drug effects
Phosphotransferases (Alcohol Group Acceptor)*/antagonists & inhibitors
Triazoles*/chemistry
Triazoles*/pharmacology
HEK293 Cells ; Humans ; Microbial Sensitivity Tests ; Molecular Docking Simulation ; Shikimic Acid ; Structure-Activity Relationship ; Tuberculosis/drug therapy
Czasopismo naukowe
Tytuł:
Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease.
Autorzy:
Yao Q; Department of Radiology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Zhou QH; Department of Allergy and Clinical Immunology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Shen QL; Department of Radiology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Wang XC; Department of Allergy and Clinical Immunology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Hu XH; Department of Radiology, Children's Hospital of Fudan University, Shanghai, 201102, China. .; Cardiac Center, Children's Hospital of Fudan University, Shanghai, 201102, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 11; Vol. 12 (1), pp. 11765. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Journal Article
MeSH Terms:
BCG Vaccine*/adverse effects
Granulomatous Disease, Chronic*/complications
Lymphadenopathy*
Tuberculosis, Pulmonary*/diagnostic imaging
Bacillus ; Humans ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Analysis of efficacy and safety of linezolid-based chemotherapeutic regimens for patients with postoperative multidrug-resistant spinal tuberculosis.
Autorzy:
Qiao J; Department of Orthopedics, The Central Hospital of Wuhan, Wuhan, China; Hubei University of Chinese Medicine,Wuhan, China.
Yang L; Department of Orthopedics, Wuhan No.1 Hospital, Wuhan, China.
Feng J; Department of Orthopedics, Wuhan No.1 Hospital, Wuhan, China.
Dai X; Department of Surgery, Wuhan Pulmonary Hospital, Wuhan, China.
Xu F; Department of Surgery, Wuhan Pulmonary Hospital, Wuhan, China.
Xia P; Department of Orthopedics, The Central Hospital of Wuhan, Wuhan, China. Electronic address: .
Pokaż więcej
Źródło:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 May; Vol. 118, pp. 264-269. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Linezolid*/adverse effects
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/surgery
Tuberculosis, Spinal*/drug therapy
Tuberculosis, Spinal*/surgery
Humans ; Mycobacterium tuberculosis/drug effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Investigation on the cause of recurrent tuberculosis in a rural area in China using whole-genome sequencing: A retrospective cohort study.
Autorzy:
Li M; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Qiu Y; Wusheng County Center for Disease Control and Prevention, Guang'an, 638401, China.
Guo M; Wusheng County Center for Disease Control and Prevention, Guang'an, 638401, China.
Zhang S; Institution for Tuberculosis Prevention and Control, Sichuan Provincial Center for Disease Control and Prevention, Chengdu, 610041, China.
Wang G; Wusheng County Center for Disease Control and Prevention, Guang'an, 638401, China.
Wang Y; Wusheng County Center for Disease Control and Prevention, Guang'an, 638401, China.
Xia L; Institution for Tuberculosis Prevention and Control, Sichuan Provincial Center for Disease Control and Prevention, Chengdu, 610041, China. Electronic address: .
Gao Q; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: .
Pokaż więcej
Źródło:
Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2022 Mar; Vol. 133, pp. 102174. Date of Electronic Publication: 2022 Jan 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Antitubercular Agents/therapeutic use ; China/epidemiology ; Female ; Humans ; Male ; Recurrence ; Reinfection ; Retrospective Studies ; Tuberculosis, Multidrug-Resistant/diagnosis ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/epidemiology
Czasopismo naukowe
Tytuł:
Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis.
Autorzy:
Bomfim CCB; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Fisher L; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Amaral EP; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Mittereder L; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
McCann K; Laboratory of Clinical Immunology and Microbiology - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Correa AAS; Department of Biochemistry and Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.; Graduate Program in Basic and Applied Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Namasivayam S; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Swamydas M; Laboratory of Clinical Immunology and Microbiology - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Moayeri M; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Weiss JM; Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, MD, United States.
Chari R; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
McVicar DW; Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, MD, United States.
Costa DL; Department of Biochemistry and Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.; Graduate Program in Basic and Applied Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
D'Império Lima MR; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Sher A; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Pokaż więcej
Źródło:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 May 02; Vol. 12, pp. 862582. Date of Electronic Publication: 2022 May 02 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
MeSH Terms:
Hydro-Lyases*/biosynthesis
Hydro-Lyases*/immunology
Macrophages*/immunology
Macrophages*/microbiology
Membrane Proteins*/metabolism
Mycobacterium tuberculosis*/metabolism
Receptor, Interferon alpha-beta*/metabolism
Toll-Like Receptor 2*/metabolism
Adaptor Proteins, Signal Transducing/metabolism ; Animals ; Enzyme Induction ; Mice ; Myeloid Differentiation Factor 88/metabolism ; NF-kappa B/metabolism ; Phagocytosis ; Tuberculosis/metabolism ; Tuberculosis/microbiology
Czasopismo naukowe
Tytuł:
RNA Expression Analysis of Mycobacterial Methyltransferases Genes in Different Resistant Strains of Mycobacterium tuberculosis.
Autorzy:
Tarashi S; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Zamani MS; Immunoregulation Research Center, Shahed University, Tehran, Iran.
Bahramali G; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.; Viral Vaccine Research Center, Pasteur Institute of Iran, Tehran, Iran.
Fuso A; Department of Experimental Medicine, Sapienza University of Rome, Italy.
Vaziri F; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Karimipoor M; Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Fateh A; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Siadat SD; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Pokaż więcej
Źródło:
Iranian biomedical journal [Iran Biomed J] 2022 May 01; Vol. 26 (3), pp. 240-51. Date of Electronic Publication: 2022 May 01.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Bacterial*
Methyltransferases*/genetics
Methyltransferases*/metabolism
Mycobacterium tuberculosis*/enzymology
Mycobacterium tuberculosis*/genetics
Virulence Factors*/genetics
Humans ; Microbial Sensitivity Tests ; Mutation ; RNA, Bacterial/genetics ; Tuberculosis
Czasopismo naukowe
Tytuł:
Up-regulated SAMD9L modulated by TLR2 and HIF-1α as a promising biomarker in tuberculosis.
Autorzy:
Zhang XJ; Department of Pathogen Biology, School of Basic Medicine, Weifang Medical University, Weifang, China.; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Xu HS; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Li CH; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Fu YR; Department of Pathogen Biology, School of Basic Medicine, Weifang Medical University, Weifang, China.; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Yi ZJ; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2022 May; Vol. 26 (10), pp. 2935-2946. Date of Electronic Publication: 2022 Apr 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypoxia-Inducible Factor 1, alpha Subunit*/genetics
MicroRNAs*/genetics
Toll-Like Receptor 2*/genetics
Tuberculosis*/diagnosis
Tuberculosis*/genetics
Tumor Suppressor Proteins*/genetics
Biomarkers ; Humans ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Leukoplakia or LPR: The Misdiagnosis of Laryngeal Tuberculosis.
Autorzy:
Lou ZC; Department of Otorhinolaryngology, 118369Yiwu Central Hospital, Yiwu, Zhejiang, China.
Li X; Department of Otolaryngology, 117947Jining No. 1 People's Hospital, Jining, Shandong, China.
Pokaż więcej
Źródło:
Ear, nose, & throat journal [Ear Nose Throat J] 2021 Sep; Vol. 100 (5_suppl), pp. 549S-553S. Date of Electronic Publication: 2019 Nov 29.
Typ publikacji:
Journal Article
MeSH Terms:
Diagnostic Errors*
Mycobacterium tuberculosis*
Laryngopharyngeal Reflux/*diagnosis
Leukoplakia/*diagnosis
Tuberculosis, Laryngeal/*diagnosis
Adult ; Aged ; Diagnosis, Differential ; Epiglottis/pathology ; Epiglottitis/diagnosis ; Female ; Humans ; Larynx/diagnostic imaging ; Larynx/microbiology ; Lung/diagnostic imaging ; Lung/microbiology ; Male ; Middle Aged ; Retrospective Studies ; Tuberculosis, Laryngeal/microbiology ; Tuberculosis, Pulmonary/complications ; Tuberculosis, Pulmonary/diagnostic imaging ; Vocal Cords/pathology
Czasopismo naukowe
Tytuł:
The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic Mechanisms.
Autorzy:
Wigger GW; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Bouton TC; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, United States.
Jacobson KR; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, United States.
Auld SC; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.; Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Yeligar SM; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.; Atlanta VA Medical Center, Atlanta, GA, United States.
Staitieh BS; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Mar 31; Vol. 13, pp. 864817. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
Alcoholism*/complications
Alcoholism*/epidemiology
Tuberculosis*/complications
Alcohol Drinking/adverse effects ; Alcohol Drinking/epidemiology ; Ethanol ; Humans ; Macrophages, Alveolar ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Mice Dually Disrupted for Nod2 and Mincle Manifest Early Bacteriological Control but Late Susceptibility During Mycobacterium tuberculosis Infection.
Autorzy:
Dubé JY; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; McGill International TB Centre, Montréal, QC, Canada.
McIntosh F; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; McGill International TB Centre, Montréal, QC, Canada.
Behr MA; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; McGill International TB Centre, Montréal, QC, Canada.; Department of Medicine, McGill University Health Centre, Montréal, QC, Canada.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Mar 28; Vol. 13, pp. 862992. Date of Electronic Publication: 2022 Mar 28 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lectins, C-Type*/genetics
Membrane Proteins*/genetics
Nod2 Signaling Adaptor Protein*/genetics
Tuberculosis*
Animals ; Lung ; Mice ; Mice, Knockout ; Mycobacterium tuberculosis ; Receptors, Pattern Recognition
Czasopismo naukowe
Tytuł:
Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis?
Autorzy:
Sivakumaran D; Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Jenum S; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Ritz C; Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
Vaz M; Department of Physiology, St. John's Medical College, Bangalore, India.; Division of Health and Humanities, St. John's Research Institute, Bangalore, India.
Doherty TM; GlaxoSmithKline Vaccines, Wavre, Belgium.
Grewal HMS; Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Mar 17; Vol. 13, pp. 801616. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis*/prevention & control
Biomarkers/analysis ; Cytokines/analysis ; Humans ; Mycobacterium tuberculosis ; Prospective Studies ; Tuberculin Test
Czasopismo naukowe
Tytuł:
Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors.
Autorzy:
Yang L; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Hu X; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Chai X; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Ye Q; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Pang J; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Li D; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Hou T; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China; State Key Lab of Computer-aided Design and Computer Graphics (CAD&CG), Zhejiang University, Hangzhou, Zhejiang 310058, China. Electronic address: .
Pokaż więcej
Źródło:
Drug discovery today [Drug Discov Today] 2022 Jan; Vol. 27 (1), pp. 326-336. Date of Electronic Publication: 2021 Sep 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/pathogenicity
Tuberculosis*/drug therapy
Tuberculosis*/microbiology
Antitubercular Agents/*pharmacology
Drug Design/*methods
Drug Development/*trends
Drug Evaluation, Preclinical/methods ; Humans ; Latent Tuberculosis/drug therapy ; Tuberculosis, Multidrug-Resistant/drug therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz